Related references
Note: Only part of the references are listed.Phase I safety and tolerability study of topical verapamil HCl in chronic rhinosinusitis with nasal polyps
Alan D. Workman et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)
Preparation and Characterization of Mucoadhesive Loratadine Nanoliposomes for Intranasal Administration
Lena Tamaddon et al.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Oral mucus-penetrating PEGylated liposomes to improve drug absorption: Differences in the interaction mechanisms of a mucoadhesive liposome
Eriko Yamazoe et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
P-glycoprotein inhibition with verapamil overcomes mometasone resistance in Chronic Sinusitis with Nasal Polyps
Maie S. Taha et al.
RHINOLOGY (2021)
Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome- Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive Liposomes
Matteo Petrini et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection
Gabriella Costabile et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Sample collection for laboratory-based study of the nasal airway and sinuses: a research compendium
Conner J. Massey et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)
Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes
Harkiranpreet Kaur Dhaliwal et al.
MOLECULAR PHARMACEUTICS (2020)
Strategies to Obtain Encapsulation and Controlled Release of Small Hydrophilic Molecules
Qi Li et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Development of Liposomal Gemcitabine with High Drug Loading Capacity
Hassan Tamam et al.
MOLECULAR PHARMACEUTICS (2019)
Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
Soon-Seok Hong et al.
PHARMACEUTICS (2019)
Diversity of PEGylation methods of liposomes and their influence on RNA delivery
A. S. Nosova et al.
MEDCHEMCOMM (2019)
PEGylation for enhancing nanoparticle diffusion in mucus
Justin T. Huckaby et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Verapamil and riluzole cocktail liposomes overcome pharmacoresistance by inhibiting P-glycoprotein in brain endothelial and astrocyte cells: A potent approach to treat amyotrophic lateral sclerosis
Tianzhi Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia
Laurent Salade et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Jasmim Leal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps
Marcel M. Miyake et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies
Sara Nageeb El-Helaly et al.
DRUG DELIVERY (2017)
P-glycoprotein regulates Staphylococcus aureus enterotoxin B-stimulated interleukin-5 and thymic stromal lymphopoietin secretion in organotypic mucosal explants
Benjamin S. Bleier et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2016)
Composite chitosan-transfersomal vesicles for improved transnasal permeation and bioavailability of verapamil
Mamdouh Abdel Mouez et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Rationally designed nanocarriers for intranasal therapy of allergic rhinitis: influence of carrier type on in vivo nasal deposition
Marwa Ahmed Sallam et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice
Rui Tada et al.
PLOS ONE (2015)
Verapamil modulates interleukin-5 and interleukin-6 secretion in organotypic human sinonasal polyp explants
Benjamin S. Bleier et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2015)
Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres
Mamdouh Abdel Mouez et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
P-glycoprotein promotes epithelial T helper 2-associated cytokine secretion in chronic sinusitis with nasal polyps
Benjamin S. Bleier et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2014)
P-glycoprotein inhibition promotes prednisone retention in human sinonasal polyp explants
Armine Kocharyan et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2014)
P-glycoprotein is a marker of tissue eosinophilia and radiographic inflammation in chronic rhinosinusitis without nasal polyps
Rachel E. Feldman et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2013)
Nasal drug delivery
Elka Touitou et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis
M. Boehm et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2012)
Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers
Sadayuki Hashioka et al.
NEUROPHARMACOLOGY (2012)
Effect of verapamil on bronchial goblet cells of asthma: An experimental study on sensitized animals
Mohammad Reza Khakzad et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2012)
Regional expression of epithelial MDR1/P-glycoprotein in chronic rhinosinusitis with and without nasal polyposis
Benjamin S. Bleier
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2012)
Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus
Samuel K. Lai et al.
BIOMATERIALS (2011)
Calcium Channel Blockers Differentially Modulate Cytokine Production by Peripheral Blood Mononuclear Cells
Akira Matsumori et al.
CIRCULATION JOURNAL (2010)
Epithelium, Cilia, and Mucus: Their Importance in Chronic Rhinosinusitis
Marcelo B. Antunes et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2009)
HPLC method for determination of verapamil in human plasma after solid-phase extraction
Violeta Ivanova et al.
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2008)
Verapamil modulates LPS-induced cytokine production via inhibition of NF-kappa B activation in the liver
G Li et al.
INFLAMMATION RESEARCH (2006)
Share Paper
